Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Products
  • Duloxetine Delayed-Release Capsules
Where it was sold

Nationwide in the USA.

Nationwide

Units affected
1223 bottles
About this recall
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99